Data from a mouse model indicated that the injection of recombinant VEGF into tumor-free mice results in suppressed development of DCs related to Gr-1+ immature myeloid-derived suppressor cell (MDSC) accumulation, leading to an inhibition of T cell functions [25]. This evidence concerns the gene VEGFA and neoplasm.